Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum

1. VKTX stock nearing a potential death cross, indicating bearish signals. 2. Stock has dropped 25.69% in the last month; shows weak trading momentum. 3. Analysts question VKTX's competitiveness in the lucrative obesity drug market. 4. Potential upside exists if VKTX provides favorable clinical updates soon. 5. Stock remains below key moving averages, signaling broader technical weakness.